NCT01033136

Brief Summary

To evaluate the feasibility, acceptability and effectiveness of Multiple Channel Exposure Therapy-Veterans (MCET-V) as a treatment for returning service members with comorbid PTSD and panic disorder (PD). This study will examine the effectiveness of MCET-V by comparing it to Cognitive Processing Therapy, a standard PTSD treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
93

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2013

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 3, 2009

Completed
13 days until next milestone

First Posted

Study publicly available on registry

December 16, 2009

Completed
3 years until next milestone

Study Start

First participant enrolled

January 1, 2013

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2016

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2017

Completed
1.5 years until next milestone

Results Posted

Study results publicly available

July 20, 2018

Completed
Last Updated

September 17, 2018

Status Verified

August 1, 2018

Enrollment Period

3.7 years

First QC Date

December 3, 2009

Results QC Date

September 29, 2017

Last Update Submit

August 17, 2018

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in PTSD Symptoms (CAPS) Between MCET-V and CPT Groups

    The CAPS is a clinician-administered assessment of the presence and severity of PTSD symptoms. Scores range from 0 - 136, with higher scores indicating greater symptom severity.

    Baseline, 1-week post-treatment and 3-month follow-up

  • Change in PDSS Scores Over Time for MCET-V and CPT Groups

    The Panic Disorder Severity Scale (PDSS) is a clinician-rated assessment of the presence and severity of panic symptoms. Scores range from 0 - 28, with higher scores indicating greater symptom severity.

    Baseline, 1-week post, and 3-month follow-up

Study Arms (2)

MCET-V

EXPERIMENTAL

Multiple Channel Exposure Therapy -Veterans (MCET-V) is a 12-session cognitive-behavioral treatment for persons with comorbid PTSD and panic attacks. It is an integrated treatment designed to target panic and PTSD symptoms simultaneously.

Behavioral: Multiple Channel Exposure Therapy - Veterans

CPT

ACTIVE COMPARATOR

Cognitive Processing Therapy (CPT) is a 12-session cognitive-behavioral treatment for persons with PTSD. It is a gold-standard cognitive behavioral intervention designed to target PTSD symptoms.

Behavioral: Cognitive Processing Therapy

Interventions

MCET-V offers individual therapy that provides psychoeducation about panic attacks and trauma and involves behavioral and cognitive exposure exercises.

Also known as: MCET-V
MCET-V

CPT offers individual therapy that targets trauma and PTSD symptoms via cognitive restructuring.

Also known as: CPT
CPT

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • being a Veteran of any era;
  • being enrolled in the TRP at the MEDVAMC, with a current diagnosis of PTSD and PD;
  • being stable on psychotropic medication for 4 weeks before study participation; and
  • being at least 18 years of age.

You may not qualify if:

  • active substance dependence, or bipolar or psychotic disorders;
  • severe depression and \[active suicidal ideation and intent\] (based on ADIS-IV \& BDI-II);
  • cognitive impairment as indicated by the SLUMS; and
  • Veterans currently receiving psychosocial treatment specifically targeting PTSD or panic symptoms.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Michael E. DeBakey VA Medical Center, Houston, TX

Houston, Texas, 77030, United States

Location

MeSH Terms

Conditions

Stress Disorders, Post-TraumaticPanic Disorder

Interventions

2-cyclohexylidenhydrazo-4-phenyl-thiazole

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental DisordersAnxiety Disorders

Results Point of Contact

Title
Dr. Ellen Teng
Organization
Michael E. DeBakey VA Medical Center

Study Officials

  • Ellen Teng, PhD

    Michael E. DeBakey VA Medical Center, Houston, TX

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Post-treatment and follow-up assessments are conducted by an assessor masked to treatment condition.
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Multiple Channel Exposure Therapy is a behavioral treatment that simultaneously targets panic disorder and PTSD.
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 3, 2009

First Posted

December 16, 2009

Study Start

January 1, 2013

Primary Completion

September 30, 2016

Study Completion

January 1, 2017

Last Updated

September 17, 2018

Results First Posted

July 20, 2018

Record last verified: 2018-08

Data Sharing

IPD Sharing
Will not share

Locations